Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen

被引:79
|
作者
Flashman, Emily [1 ,2 ]
Hoffart, Lee M. [3 ,4 ]
Hamed, Refaat B. [1 ,2 ,5 ]
Bollinger, J. Martin, Jr. [3 ,4 ]
Krebs, Carsten [3 ,4 ]
Schofield, Christopher J. [1 ,2 ]
机构
[1] Univ Oxford, Dept Chem, Oxford OX1 3TA, England
[2] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England
[3] Penn State Univ, Dept Chem, University Pk, PA 16802 USA
[4] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA
[5] Assiut Univ, Dept Pharmacognosy, Fac Pharm, Assiut, Egypt
基金
英国工程与自然科学研究理事会; 美国国家卫生研究院;
关键词
2-oxoglutarate; hypoxia-inducible factor; oxygen; oxygenase; prolyl hydroxylase; spectroscopy; ALPHA-KETOGLUTARATE DIOXYGENASE; SPIN FE(IV) INTERMEDIATE; FACTOR INHIBITING HIF; ESCHERICHIA-COLI; ACTIVE-SITE; DEPENDENT DIOXYGENASE; ALIPHATIC HALOGENASE; CLAVAMINATE SYNTHASE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE;
D O I
10.1111/j.1742-4658.2010.07804.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The response of animals to hypoxia is mediated by the hypoxia- inducible transcription factor. Human hypoxia- inducible factor is regulated by four Fe( II)- and 2- oxoglutarate- dependent oxygenases: prolyl hydroxylase domain enzymes 1- 3 catalyse hydroxylation of two prolyl- residues in hypoxia- inducible factor, triggering its degradation by the proteasome. Factor inhibiting hypoxia- inducible factor catalyses the hydroxylation of an asparagine- residue in hypoxia- inducible factor, inhibiting its transcriptional activity. Collectively, the hypoxia- inducible factor hydroxylases negatively regulate hypoxia- inducible factor in response to increasing oxygen concentration. Prolyl hydroxylase domain 2 is the most important oxygen sensor in human cells; however, the underlying kinetic basis of the oxygen- sensing function of prolyl hydroxylase domain 2 is unclear. We report analyses of the reaction of prolyl hydroxylase domain 2 with oxygen. Chemical quench / MS experiments demonstrate that reaction of a complex of prolyl hydroxylase domain 2, Fe( II), 2- oxoglutarate and the C- terminal oxygendependent degradation domain of hypoxia- inducible factor-alpha with oxygen to form hydroxylated C- terminal oxygen- dependent degradation domain and succinate is much slower ( approximately 100- fold) than for other similarly studied 2- oxoglutarate oxygenases. Stopped flow/ UV- visible spectroscopy experiments demonstrate that the reaction produces a relatively stable species absorbing at 320 nm; Mossbauer spectroscopic experiments indicate that this species is likely not a Fe( IV)= O intermediate, as observed for other 2- oxoglutarate oxygenases. Overall, the results obtained suggest that, at least compared to other studied 2- oxoglutarate oxygenases, prolyl hydroxylase domain 2 reacts relatively slowly with oxygen, a property that may be associated with its function as an oxygen sensor.
引用
收藏
页码:4089 / 4099
页数:11
相关论文
共 50 条
  • [41] Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Heart Failure with Preserved Ejection Fraction
    Imamura, Teruhiko
    Hori, Masakazu
    Tanaka, Shuhei
    Kinugawa, Koichiro
    MEDICINA-LITHUANIA, 2021, 57 (12):
  • [42] Pyrithione Zn selectively inhibits hypoxia-inducible factor prolyl hydroxylase PHD3
    Na, Yu-Ran
    Woo, Dustin J.
    Kim, So Yeon
    Yang, Eun Gyeong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 472 (02) : 313 - 318
  • [43] Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Renal Function in Patient with Heart Failure
    Imamura, Teruhiko
    Ueno, Yohei
    Kinugawa, Koichiro
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (12)
  • [44] Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
    Johnson, Haley N.
    Prasad-Reddy, Lalita
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (01) : 71 - 80
  • [45] Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure
    Yazaki, Mayu
    Nabeta, Takeru
    Takigami, Yu
    Eda, Yuko
    Fujita, Teppei
    Iida, Yuichiro
    Ikeda, Yuki
    Ishii, Shunsuke
    Ako, Junya
    MEDICINA-LITHUANIA, 2024, 60 (01):
  • [46] Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in maintenance dialysis: a meta-analysis
    Meiyan Wu
    Chongsen Zang
    Fuzhe Ma
    Bin Chen
    Juan Liu
    Zhonggao Xu
    Clinical and Experimental Nephrology, 2022, 26 : 1043 - 1054
  • [47] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
    Gupta, Nupur
    Wish, Jay B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (06) : 815 - 826
  • [48] Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in maintenance dialysis: a meta-analysis
    Wu, Meiyan
    Zang, Chongsen
    Ma, Fuzhe
    Chen, Bin
    Liu, Juan
    Xu, Zhonggao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (11) : 1043 - 1054
  • [49] Assessing the Carcinogenicity of Vadadustat, an Oral Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase Inhibitor, in Rodents
    Conboy, H. L.
    Hoivik, D. J.
    Rabinowitz, M.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022, 41 (01) : 71 - 71
  • [50] Melanoma Antigen-11 Inhibits the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 and Activates Hypoxic Response
    Aprelikova, Olga
    Pandolfi, Silvia
    Tackett, Sean
    Ferreira, Mark
    Salnikow, Konstantin
    Ward, Yvona
    Risinger, John I.
    Barrett, J. Carl
    Niederhuber, John
    CANCER RESEARCH, 2009, 69 (02) : 616 - 624